Year of Birth: 1964 

Nationality: Polish, Swiss resident 

Independence: Independent 

 

Current Position: 

• 2012-present: Advisory Partner, Poland (since 2026); Chairman, Poland (since 2024); Head of Private Equity & Strategy Practice, Poland (since 2012); Senior Partner, Poland (2012-2026), Founder / Managing Partner (2012-2024), Bain & Company, Central and Eastern Europe 

 

Special Qualifications / Key Skills / Expertise / Competences for DM: 
 

Healthcare

• Multi-year advisory experience across European healthcare systems, including pharmacy retail, online pharmacy, diagnostics, outpatient/hospital care, health insurance, and pharmaceutical distribution 

• Directed strategy work and due diligence for major pharmacy chains, online pharmacies, diagnostics groups, and hospital networks across Germany, Switzerland, Italy, Spain, Nordics, France and Central and Eastern Europe 

• Multi-year leadership and advisory work for healthcare and pharmaceutical players including business model design, NPS implementation, and preparation of commercial documentation for investor entry 

• Pan‑European exposure includes diagnostics and specialist care with strong activity in core EU markets (incl. Germany), plus advisory to outpatient/hospital providers and health insurance strategy work 

• Supported portfolio moves in medicines and generics, including advisory to pan‑European acquisitions 
   

German healthcare regulatory experience 

• Advised across the full healthcare value chain – online pharmacy, retail pharmacy, wholesale/distribution – covering due diligence, regulatory sensitivity, strategy, organizational redesign, pricing/sales optimization and investor‑entry preparation 

• Orchestrated business model adaptations in pharmacy and wholesale distribution, including pricing/sales optimization, and vendor diligence supporting multiple healthcare transactions 
   

E-commerce and digital platform expertise & low-margin retail operations 

• Extensive work on due diligence of online pharmacy targets, strategy for retail and e‑commerce pharmacy divisions, and omnichannel growth strategies for health & beauty retailers 

• Led strategic and operational work for pan-European e-commerce players and PE-backed digital logistics companies 

• Guided digital transformation programs, including omnichannel architecture, digital health solutions, and implementation of patient-focused technology models (e.g., e-doctor solution during COVID) 

• Broader digital‑transformation exposure across pharmacy, healthcare and retail, including omnichannel models, digital customer experience and technology‑enabled operating‑model enhancements 

• Advised on growth, pricing and digital acceleration across low‑margin retail formats – including pharmacy, grocery retail, convenience chains, and fashion retail 

• Delivered savings and margin expansion programs for large retailers managing high-volume, low-margin operations 

• Advised on acquisitions and value-creation plans for major grocery and convenience retail chains in various countries 

• Delivered quantifiable cost impact in high‑volume retail and wholesale (e.g., “profit hunt” savings), reinforcing low‑margin operating expertise 
   

Strategic transformation experience 

• Transformation specialist with a career focus on large‑scale strategy, value creation programs, M&A and enterprise‑wide transformation programs across sectors and geographies 

• Led 250+ due diligence, value creation, and transformation programs for PE investors, family offices, and corporates 

• Designed and implemented large-scale restructurings: telecom opex/capex optimization (CHF 510M cumulative impact), transportation restructuring, international post-merger integration across energy, chemicals, food processing, and logistics 

• Supported international expansion, organizational redesign and new business building for healthcare players and major retailers 

• Supported founders and boards during high-stakes transformations, including IPO readiness and market-entry strategy 

• Led value creation plans and regulatory‑driven business model adaptations in pharmacy and regulated wholesale, tying growth strategy to e‑commerce acceleration 

• Scaled post‑deal value creation via 100‑day programs, strategy execution and portfolio reviews across consumer, retail, e‑commerce and digital‑logistics assets 

• Led large‑scale operating‑model, data and infrastructure modernization in telecom alongside opex/capex optimization 
   

AI         

• Led digital and AI capability reviews for private equity portfolios across healthcare, pharmacy, retail, and e-commerce 

• Supported digital strategy definition for a grocery retailer 
   

Financial 

• 25 years advising global and regional PE funds and financial/corporate investors on more than 250 buy-side & sell-side diligences, equity story and business plan development, and exit preparation; delivered portfolio strategies and financial‑improvement programs post-acquisition 

• Extensive involvement in IPO readiness, strategic or financial investor sale, capital increase documentation, and investor communications for healthcare, diagnostics, retail and e-commerce companies 

• Broad experience in sales simulation and pricing, cost base optimization, opex/capex optimization, and financial restructuring 

• Advised 3 listed companies in healthcare, chemicals and industrials on major cross-border acquisitions including M&A strategy, due diligence, post-merger integration 

• Commercial vendor due diligence for a large diagnostics IPO and capital‑increase/investor‑entry preparation for pharmacy businesses 

• Pre‑investment screening via industry scans and portfolio reviews supporting buy‑ and sell‑side decisions across healthcare, retail and logistics 
   

Public company experience (director) 

• 2011-2015: Non-Executive Director, KGHM S.A., Poland / KGHM International, Canada 
   

Investments 

• Advisor to investors on multibillion-Swiss-franc transactions across pharmacy, diagnostics, digital logistics, retail sectors and healthcare alongside IPO/exit pathways 

• Led pre-investment screening, commercial due diligence, vendor due diligence, and portfolio assessments for PE funds 

• Advised sponsors and owners on investor processes and exit pathways across pharmacy and healthcare assets  

• Buy‑ and sell‑side diligence for European online pharmacies and transaction preparation for digital‑health and retail assets (incl. sell‑side processes) 

 

Professional Career: 

• 2012-present: Advisory Partner, Poland (since 2026); Chairman, Poland (since 2024); Head of Private Equity & Strategy Practice, Poland (since 2012); Senior Partner, Poland (2012-2026), Founder / Managing Partner (2012-2024), Bain & Company, Central and Eastern Europe 

• 1992-2012: Senior Partner / Managing Partner Poland (2005-2011) / Director, Partner / Principal, Consultant / Manager, McKinsey & Company, Denmark / Canada / Poland 

• 1987-1990: Analyst, Chrysler Motors Corporation, USA 

 

Qualifications / Education: 

• 1990-1992: Master of Business Administration, Columbia Business School, USA 

• 1983-1987: Bachelor’s degree, Warsaw School of Economics, Poland 

 

Board of Directors / Supervisory Boards / Advisory Boards: 

Mandates in Advisory Boards: 

• 2026-present: Advisor to the Board, OSHEE Polska S.A., Poland